2. Search Result
Search Result
Results for "

proprotein convertase 1

" in MedChemExpress (MCE) Product Catalog:

1

Inhibitors & Agonists

1

Peptides

6

Recombinant Proteins

1

Antibodies

Species:
Tag:
Source:
Cat. No. Compare Product Name Species Source
  • HY-P72405
    PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, Avi)

    Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9

    		 Human HEK293
    PCSK9 protein, a crucial regulator of plasma cholesterol homeostasis, influences LDL receptor family members like LDLR and VLDLR. It facilitates their degradation within intracellular compartments, enhancing hepatic LDLR degradation through a non-proteolytic mechanism. PCSK9 also exhibits LDLR-independent inhibition of APOB degradation and regulates ENaC-mediated Na(+) absorption, influencing neuronal apoptosis. Notably, it modulates LRP8/APOER2 levels and associated anti-apoptotic pathways. PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, Avi) is the recombinant human-derived PCSK9 protein, expressed by HEK293 , with C-Avi labeled tag and V474I, G670E mutation. The total length of PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, Avi) is 662 a.a., with molecular weight of 19 & 65 kDa, respectively.
  • HY-P71189A
    PCSK9 Protein, Mouse (HEK293, His)

    proprotein convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; Pcsk9; Narc1

    		 Mouse HEK293
    The PCSK9 protein regulates cholesterol levels by degrading LDLR, VLDLR, LRP1/APOER, and LRP8/APOER2 receptors. It promotes LDLR degradation, inhibits recycling, induces ubiquitination, and affects APOB degradation. Additionally, PCSK9 influences BACE1 intermediates, ENaC surface expression, and neuronal apoptosis by modulating LRP8/APOER2 levels and anti-apoptotic signaling pathways. PCSK9 Protein, Mouse (HEK293, His) is a recombinant protein dimer complex containing mouse-derived PCSK9 protein, expressed by HEK293 , with C-6*His labeled tag. PCSK9 Protein, Mouse (HEK293, His), has molecular weight of 19.37 & 55 kDa, respectively.
  • HY-P71189
    PCSK9 Protein, Mouse (HEK293, His, solution)

    proprotein convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; Pcsk9; Narc1

    		 Mouse HEK293
    The PCSK9 protein regulates cholesterol levels by degrading LDLR, VLDLR, LRP1/APOER, and LRP8/APOER2 receptors. It promotes LDLR degradation, inhibits recycling, induces ubiquitination, and affects APOB degradation. Additionally, PCSK9 influences BACE1 intermediates, ENaC surface expression, and neuronal apoptosis by modulating LRP8/APOER2 levels and anti-apoptotic signaling pathways. PCSK9 Protein, Mouse (HEK293, His, solution) is a recombinant protein dimer complex containing mouse-derived PCSK9 protein, expressed by HEK293, with C-6*His labeled tag. PCSK9 Protein, Mouse (HEK293, His, solution), has molecular weight of 17-19 & 60-66 kDa, respectively.
  • HY-P70545A
    PCSK9 Protein, Human (HEK293, C-His)
    1 Publications Verification

    proprotein convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; PCSK9; NARC1

    		 Human HEK293
    The PCSK9 protein is an important regulator of plasma cholesterol homeostasis, affecting LDL receptor family members such as LDLR and VLDLR. It promotes their intracellular degradation and enhances hepatic LDLR degradation through non-proteolytic mechanisms. PCSK9 Protein, Human (HEK293, C-His) is the recombinant human-derived PCSK9 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of PCSK9 Protein, Human (HEK293, C-His) is 662 a.a., with molecular weight of approximately 20.33 & 59 kDa, respectively.
  • HY-P70545
    PCSK9 Protein, Human (HEK293, V474I, G670E, His)

    proprotein convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; PCSK9; NARC1

    		 Human HEK293
    The PCSK9 protein is an important regulator of plasma cholesterol homeostasis, affecting LDL receptor family members such as LDLR and VLDLR. It promotes their intracellular degradation and enhances hepatic LDLR degradation through non-proteolytic mechanisms. PCSK9 Protein, Human (HEK293, V474I, G670E, His) is the recombinant human-derived PCSK9 protein, expressed by HEK293 , with C-6*His labeled tag and V474I, G670E, , , mutation. The total length of PCSK9 Protein, Human (HEK293, V474I, G670E, His) is 662 a.a., with molecular weight of 19 & 60 kDa, respectively.
  • HY-P70546
    PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, His-HA-Avi)

    proprotein convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated convertase 1; NARC-1; proprotein convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; PCSK9; NARC1

    		 Human HEK293
    The PCSK9 protein is an important regulator of plasma cholesterol homeostasis, affecting LDL receptor family members such as LDLR and VLDLR. It promotes their intracellular degradation and enhances hepatic LDLR degradation through non-proteolytic mechanisms. PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, His-HA-Avi) is the recombinant human-derived PCSK9 protein, expressed by HEK293 , with C-Avi, C-HA, C-8*His labeled tag and V474I, G670E, , , mutation. The total length of PCSK9 Protein, Human (Biotinylated, V474I, G670E, HEK293, His-HA-Avi) is 662 a.a., with molecular weight of 18 & 58-70 & 90-150 kDa, respectively.

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: